Brilliant N.E.V. Corp. Narrows Q3 Loss 87% to $9,781 as Expenses Collapse

Brilliant N.E.V. Corp., a Nevada-incorporated development-stage company, reported a net loss of $9,781 for the three months ending April 30, 2024, an 87% improvement from the $77,987 loss recorded in the same quarter a year earlier. Read more earnings reports.

The company reported no revenue for the quarter. Operating expenses dropped to $9,781 from $78,004 in the year-ago period, a reduction of nearly $68,000 driven primarily by the elimination of research and development spending. The company reported zero R&D expenses in the current quarter compared to $11,943 in the prior-year quarter.

For the nine months ending April 30, 2024, Brilliant N.E.V. posted a cumulative net loss of $36,015 on operating expenses of $36,015, compared to a $241,055 loss on $241,094 in expenses for the same nine-month period in fiscal 2023. The company spent nothing on R&D during the nine-month period, down from $53,477 a year earlier.

Balance Sheet Deteriorates Despite Cash Infusion

Total assets stood at $8,846 as of April 30, 2024, up from $1,302 at the end of fiscal 2023 on July 31, 2023. The entire asset base consisted of cash and cash equivalents, which increased nearly sevenfold during the period.

Total liabilities surged to $50,262 from $6,703 over the same timeframe, a 650% increase. Accounts payable declined to $1,117 from $2,321. Stockholders' equity remained deeply negative at -$41,416, though improving from -$5,401 at fiscal year-end and -$731,316 at the end of the prior-year nine-month period.

The accumulated deficit widened to -$308,854 from -$272,839 at July 31, 2023, reflecting the ongoing losses. The company had 153.1 million shares outstanding at quarter-end, unchanged from the prior fiscal year-end.

Cash Flow and Financing

Cash used in operations totaled $37,219 for the nine months ending April 30, 2024, a substantial improvement from the $195,606 burn in the prior-year period. The company raised $44,763 from financing activities during the nine-month period, down from $200,552 a year earlier.

Cash and restricted cash declined to $8,846 as of April 30, 2024, from $23,994 at the end of the prior-year nine-month period. Earnings per share rounded to $0.00 on both a basic and diluted basis for the quarter, consistent with the year-ago period.